Article Information
History
- September 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Diana López-Farfán1,
- R. Serge Yerbanga2,
- Marina Parres-Mercader1,
- Manuela Torres-Puente3,
- Inmaculada Gómez-Navarro3,
- Do Malick Soufiane Sanou2,
- Adama Franck Yao2,
- Jean Bosco Ouédraogo2,
- Iñaki Comas3,4,
- Nerea Irigoyen4 and
- Elena Gómez-Díaz1,*
- 1Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas (IPBLN-CSIC), Granada, Spain
- 2Institut de Recherche en Sciences de la Santé, Bobo-Dioulasso, Burkina Faso
- 3Institute of Biomedicine of Valencia (IBV-CSIC), Valencia, Spain
- 4CIBER in Epidemiology and Public Health, Madrid, Spain
- 5Division of Virology, Department of Pathology, University of Cambridge, Cambridge, UK
- ↵*Correspondence:
Elena Gómez-Díaz, elena.gomez{at}csic.es
Posted September 20, 2022.
Prevalence of SARS-CoV-2 and co-occurrence/co-infection with malaria during the first wave of the pandemic (the Burkina Faso case)
